1 October 2023 false Taxfiler 2024.7.2 11592190business:PrivateLimitedCompanyLtd2023-10-012024-09-30 115921902023-09-30 115921902023-10-012024-09-30 11592190business:AuditExemptWithAccountantsReport2023-10-012024-09-30 11592190business:FilletedAccounts2023-10-012024-09-30 115921902024-09-30 11592190business:Director12023-10-012024-09-30 11592190business:RegisteredOffice2023-10-012024-09-30 115921902023-09-30 11592190core:WithinOneYear2024-09-30 11592190core:WithinOneYear2023-09-30 11592190core:AfterOneYear2024-09-30 11592190core:AfterOneYear2023-09-30 11592190core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-09-30 11592190core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-09-30 11592190core:PreviouslyStatedAmount2024-09-30 11592190core:PreviouslyStatedAmount2023-09-30 11592190business:SmallEntities2023-10-012024-09-30 11592190countries:EnglandWales2023-10-012024-09-30 11592190core:FurnitureFittings2023-10-012024-09-30 11592190core:ComputerEquipment2023-10-012024-09-30 11592190core:FurnitureFittings2023-09-30 11592190core:ComputerEquipment2023-09-30 11592190core:FurnitureFittings2024-09-30 11592190core:ComputerEquipment2024-09-30 115921902022-10-012023-09-30 iso4217:GBP xbrli:pure
Company Registration No. 11592190 (England and Wales)
E.P.G Pharma Ltd Unaudited accounts for the year ended 30 September 2024
E.P.G Pharma Ltd Unaudited accounts Contents
Page
- 2 -
E.P.G Pharma Ltd Company Information for the year ended 30 September 2024
Director
Sherif Mohamed Aboelnaga Elmasry
Company Number
11592190 (England and Wales)
Registered Office
MEDICITY NOTTINGHAM D6 BUILDING THANE ROAD NOTTINGHAM NG90 6BH ENGLAND
Accountants
KM Accountancy Services Ltd 1000 Great West Rd United Business Centre Brentford, London TW8 9DW
- 3 -
E.P.G Pharma Ltd Statement of financial position as at 30 September 2024
2024 
2023 
Notes
£ 
£ 
Fixed assets
Tangible assets
559 
1,709 
Current assets
Inventories
38,600 
20,000 
Debtors
1,397 
8,697 
Cash at bank and in hand
1,974 
5,272 
41,971 
33,969 
Creditors: amounts falling due within one year
(156,393)
(118,367)
Net current liabilities
(114,422)
(84,398)
Total assets less current liabilities
(113,863)
(82,689)
Creditors: amounts falling due after more than one year
(11,665)
(14,190)
Net liabilities
(125,528)
(96,879)
Capital and reserves
Profit and loss account
(125,528)
(96,879)
Shareholders' funds
(125,528)
(96,879)
For the year ending 30 September 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 13 March 2025 and were signed on its behalf by
Sherif Mohamed Aboelnaga Elmasry Director Company Registration No. 11592190
- 4 -
E.P.G Pharma Ltd Notes to the Accounts for the year ended 30 September 2024
1
Statutory information
E.P.G Pharma Ltd is a private company, limited by shares, registered in England and Wales, registration number 11592190. The registered office is MEDICITY NOTTINGHAM D6 BUILDING, THANE ROAD, NOTTINGHAM, NG90 6BH, ENGLAND.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Fixtures & fittings
20% Straight line basis
Computer equipment
20% Straight line basis
4
Tangible fixed assets
Fixtures & fittings 
Computer equipment 
Total 
£ 
£ 
£ 
Cost or valuation
At cost 
At cost 
At 1 October 2023
5,911 
1,014 
6,925 
At 30 September 2024
5,911 
1,014 
6,925 
Depreciation
At 1 October 2023
4,964 
252 
5,216 
Charge for the year
947 
203 
1,150 
At 30 September 2024
5,911 
455 
6,366 
Net book value
At 30 September 2024
- 
559 
559 
At 30 September 2023
947 
762 
1,709 
5
Debtors
2024 
2023 
£ 
£ 
Amounts falling due within one year
VAT
1,397 
8,697 
- 5 -
E.P.G Pharma Ltd Notes to the Accounts for the year ended 30 September 2024
6
Creditors: amounts falling due within one year
2024 
2023 
£ 
£ 
Bank loans and overdrafts
4,326 
8,874 
Taxes and social security
- 
1,216 
Loans from directors
152,067 
101,546 
Accruals
- 
6,731 
156,393 
118,367 
7
Creditors: amounts falling due after more than one year
2024 
2023 
£ 
£ 
Bank loans
11,665 
14,190 
8
Average number of employees
During the year the average number of employees was 1 (2023: 1).
- 6 -